Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04552119 · ClinicalTrials.gov registry record
Safety of Treatment of Shoulder Repair
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 138
- Enrollment target
NCT04552119: Completed study, sponsored by Smith & Nephew.
NCT04552119 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04552119 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair
Primary Outcome
Clinical success was identified by the repair failure rate defined as the need for a second repair procedure. The second repair procedure would be a repair of the original rotator cuff and/or biceps tenodesis from the index procedure.
Interventions
- DEVICE HEALICOIL Knotless PEEK
- DEVICE HEALICOIL Knotless REGENESORB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2021-01-26 |
| Est. Completion | 2024-05-24 |
What the finished NCT04552119 record still lists
NCT04552119 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which HEALICOIL Knotless PEEK is the first listed.
NCT04552119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04552119 about?
NCT04552119 is a clinical study titled "Safety of Treatment of Shoulder Repair". This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair
What is the current status of trial NCT04552119?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2021-01-26. Estimated completion is 2024-05-24.
What interventions are being tested in trial NCT04552119?
The interventions under investigation include: HEALICOIL Knotless PEEK (DEVICE), HEALICOIL Knotless REGENESORB (DEVICE).
Who is sponsoring clinical trial NCT04552119?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI